Kopitar Z, Kompa H E
Arzneimittelforschung. 1975 Oct;25(10):1469-72.
A radioimmunological method was developed for 1-cyclohexyl-3-[p-(beta-4,4-dimethyl-7-methoxy-1,3-(2H,4H)-isoquinolinedion-2-yl)phenethyl]-sulfonylurea (AR-DF 26, gliquidone, Glurenorm) estimations in plasma. The antisera were obtained by immunization of rabbits with AR-DF 26-bovine serum albumin (BSA) conjugate. The estimation is based on the competitive displacement in plasma samples of known amounts of labelled AR-DF 26, bound to a specific antibody by unknown amounts of unlabelled AR-DF 26. Concentrations of as low as 1 ng of AR-DF 26 per sample can be measured by this method. The investigations into the specificity of this reaction have shown that the antiserum is extremely specific for AR-DF 26. There is good reproducibility of the results and no differences could be found by variance analysis between different measurements of the same AR-DF 26 concentration. Since more than 70% of the plasma concentration correspond to unchanged AR-DF 26 for a longer period after application, the results of this AR-DF 26-radioimmuno assay is only minimally altered by its metabolites.
建立了一种放射免疫分析法,用于测定血浆中1-环己基-3-[对-(β-4,4-二甲基-7-甲氧基-1,3-(2H,4H)-异喹啉二酮-2-基)苯乙基]-磺酰脲(AR-DF 26,格列喹酮,糖适平)。通过用AR-DF 26-牛血清白蛋白(BSA)偶联物免疫兔子获得抗血清。该测定基于已知量的标记AR-DF 26在血浆样品中被未知量的未标记AR-DF 26竞争性取代,标记AR-DF 26与特异性抗体结合。用该方法可检测低至每个样品1 ng的AR-DF 26浓度。对该反应特异性的研究表明,抗血清对AR-DF 26具有极高的特异性。结果具有良好的重现性,对相同AR-DF 26浓度的不同测量值进行方差分析时未发现差异。由于给药后较长时间内血浆浓度的70%以上对应未变化的AR-DF 26,因此该AR-DF 26放射免疫分析的结果仅受到其代谢产物的微小影响。